Angiogenic stem cell delivery platform to augment post-infarction neovasculature and reverse ventricular remodeling

Angiogenic stem cell delivery platform to augment post-infarction neovasculature and reverse ventricular remodeling

Abstract Many cell-based therapies are challenged by the poor localization of introduced cells and the use of biomaterial scaffolds with questionable biocompatibility or bio-functionality. Endothelial progenitor cells (EPCs), a popular cell type used in cell-based therapies due to their robust angio...

Full description

Bibliographic Details
Main Authors: Hye Sook Shin, Akshara Thakore, Yuko Tada, Albert J. Pedroza, Gentaro Ikeda, Ian Y. Chen, Doreen Chan, Kevin J. Jaatinen, Shin Yajima, Eric M. Pfrender, Masashi Kawamura, Phillip C. Yang, Joseph C. Wu, Eric A. Appel, Michael P. Fischbein, YJoseph Woo, Yasuhiro Shudo
Format: Article
Language:English
Published: Nature Portfolio 2022-10-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-21510-y

Internet

https://doi.org/10.1038/s41598-022-21510-y

Similar Items